Literature DB >> 17095208

The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.

P J C Bresser1, C Seynaeve, A R Van Gool, M F Niermeijer, H J Duivenvoorden, S van Dooren, A N van Geel, M B Menke-Pluijmers, J G M Klijn, A Tibben.   

Abstract

The levels and course of psychological distress before and after prophylactic mastectomy (PM) and/or prophylactic salpingo-oophorectomy (PSO) were studied in a group of 78 women. General distress was measured through the hospital anxiety and depression scale (HADS), cancer-related distress using the impact of events scale (IES). Measurement moments were baseline (2-4 weeks prior to prophylactic surgery), and 6 and 12 months post-surgery. After PM, anxiety and cancer-related distress were significantly reduced, whereas no significant changes in distress scores were observed after PSO. At one year after prophylactic surgery, a substantial amount of women remained at clinically relevant increased levels of cancer-related distress and anxiety. We conclude that most women can undergo PM and/or PSO without developing major emotional distress. More research is needed to further define the characteristics of the women who continue to have clinically relevant increased scores after surgery, in order to offer them additional counselling.

Entities:  

Mesh:

Year:  2006        PMID: 17095208     DOI: 10.1016/j.ejca.2006.09.009

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  15 in total

1.  Heightened perception of breast cancer risk in young women at risk of familial breast cancer.

Authors:  Rachael Glassey; Moira O'Connor; Angela Ives; Christobel Saunders; Sarah O'Sullivan; Sarah J Hardcastle
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Body image issues after bilateral prophylactic mastectomy with breast reconstruction in healthy women at risk for hereditary breast cancer.

Authors:  Jessica P Gopie; Marc A M Mureau; Caroline Seynaeve; Moniek M Ter Kuile; Marian B E Menke-Pluymers; Reinier Timman; Aad Tibben
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

3.  The impact of risk-reducing gynaecological surgery in premenopausal women at high risk of endometrial and ovarian cancer due to Lynch syndrome.

Authors:  Ramona Moldovan; Sianan Keating; Tara Clancy
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

4.  Survival analysis of cancer risk reduction strategies for BRCA1/2 mutation carriers.

Authors:  Allison W Kurian; Bronislava M Sigal; Sylvia K Plevritis
Journal:  J Clin Oncol       Date:  2009-12-07       Impact factor: 44.544

5.  Looking different, feeling different: women's reactions to risk-reducing breast and ovarian surgery.

Authors:  Nina Hallowell; Brandi Baylock; Louise Heiniger; Phyllis N Butow; Deepa Patel; Bettina Meiser; Christobel Saunders; Melanie A Price
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

6.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

Authors:  Carolyn Y Fang; Carol Cherry; Karthik Devarajan; Tianyu Li; John Malick; Mary B Daly
Journal:  Gynecol Oncol       Date:  2009-01-13       Impact factor: 5.482

7.  Experience of Norwegian Female BRCA1 and BRCA2 Mutation-Carrying Participants in Educational Support Groups: a Qualitative Study.

Authors:  Marion Myklebust; Eva Gjengedal; Nina Strømsvik
Journal:  J Genet Couns       Date:  2016-04-19       Impact factor: 2.537

8.  Testicular cancer and genetics knowledge among familial testicular cancer family members.

Authors:  June A Peters; Ellen B Beckjord; Deliya R Banda Ryan; Ann G Carr; Susan T Vadaparampil; Jennifer T Loud; Larissa Korde; Mark H Greene
Journal:  J Genet Couns       Date:  2008-05-15       Impact factor: 2.537

9.  Support needs and acceptability of psychological and peer consultation: attitudes of 108 women who had undergone or were considering prophylactic mastectomy.

Authors:  Andrea F Patenaude; Sara Orozco; Xiaochun Li; Carolyn M Kaelin; Michelle Gadd; Yvedt Matory; Kathleen Mayzel; Constance A Roche; Barbara L Smith; Walden Farkas; Judy E Garber
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

10.  Unmet support needs and distress among women with a BRCA1/2 mutation.

Authors:  Ashley Farrelly; Victoria White; Bettina Meiser; Michael Jefford; Mary-Anne Young; Sandra Ieropoli; Ingrid Winship; Jessica Duffy
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.